Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 1994-1998

  Mancini, Tatiana ^a   Kola, Blerina ^a   Mantero, Franco ^b   Arnaldi, Giorgio ^a,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; HYDROCORTISONE; PROGESTERONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX FUNCTION; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EVALUATION; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LABORATORY TEST; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

17-ALPHA-HYDROXYPROGESTERONE; ADENOMA; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE; FEMALE; HUMANS; HYDROCORTISONE; KINETICS; MALE; MIDDLE AGED;

EID: 0037693131     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021644     Document Type: Article

References (30)

1. Griffing GT, Pratt H, Melby JC 1985 Biphasic plasma aldosterone responses to four single-dose ACTH regimes. J Clin Pharmacol 25:387-389
2. Nicholls MG, Espiner EA, Donald RA 1975 Plasma aldosterone response to low dose ACTH stimulation. J Clin Endocrinol Metab 41:186-188
3. Kem DC, Gomez-Sanchez C, Kramer NJ, Holland OB, Higgins JR 1975 Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man. J Clin Endocrinol Metab 40:116-124
4. Schambelan M, Brust NL, Chang BCF, Slater KL, Biglieri EG 1975 Circadian Rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 43:115-131
5. Kater CE, Biglieri EG, Brust N, Chang B, Hirai J, Irony I 1989 Stimulation and suppression of the mineralcorticoid hormones in normal subjects and adrenocortical disorders. J Clin Endocrinol Metab 10:149-164
6. Kem D, Weinberger MH, Higging JR, Kramer NJ, Gomez-Sanches C, Holland B 1978 Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46:552-560
7. Stowasser M, Klemm SA, Tunny TJ, Gordon RD 1995 Plasma aldosterone response to ACTH in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 22:460-462
8. Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP, Allolio B 1997 Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression. Clin Endocrinol (Oxf) 46:619-626
9. Arnaldi G, Mancini V, Costantini C, Giovagnetti M, Petrelli M, Masini, Bertagna X, Mantero F 1998 ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. Endocr Res 24:845-849
10. Dickstein G, Spigel D, Arad E, Sheehner C 1997 One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol 137: 172-175
11. Oelkers W, Boelke T, Bahr V, Exner P, Faust B, Harendt H 1988 Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone and 18-hydroxy corticosterone after injection of ACTH (1-39) or human corticotropin, releasing hormone in man. J Clin Endocrinol Metab 66:181-186
12. Streeten DHP 1999 Editorial: shortcomings in the low-dose (1 μg) ACTH test for the diagnosis of ACTH deficiency states. J Clin Endocrinol Metab 84:835-837
13. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644
14. Roberts NA, Barton RN, Horan MA 1990 Ageing and the sensitivity of the adrenal gland to physiological doses of ACTH in man. J Endocrinol 126:507-513
15. Ohashi M, Kato K, Nawata H, Ibayashi H 1986 Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology 32:43-51
16. Giordano R, Di Vito L, Lanfranco F, Broglio F, Benso A, Gianotti L, Grottoli S, Ghigo E, Arvat E 2001 Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24). Clin Endocrinol (Oxf) 55:259-265
17. Arvat E, DiVito L, Lanfranco F, Maccario M, Baffoni C, Rossetto R, Aimaretti G, Camanni F, Ghigo E 2000 Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab 85:3141-3146
18. Parker Jr CR, Slayden SM, Azziz R, Crabbe SL, Hines GA, Boots LR, Bae S 2000 Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotrophl in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85:48-54
19. Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F 2001 Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 44:319-329
20. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, Hillis WS, Fraser R, Connell JM 2001 An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 54:813-817
21. Inglis GC, Plouin PF, Friel EC, Davies E, Fraser R, Connell JM 2001 Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). Clin Endocrinol (Oxf) 54:725-730
22. Lebrethon MC, Naville D, Begeot M, Saez JM 1994 Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 93:1828-1833
23. Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M, Tóth M 2001 ACTH-receptor expression, regulation and role in adrenocortical tumor formation. Eur J Endocrinol 144:199-206
24. Mantero F, Arnaldi G 1999 Investigation protocol: adrenal enlargement. Clin Endocrinol (Oxf) 50:141-146
25. Kjellman M, Holst M, Backdahl M, Larsson C, Farnebo LO, Wedell A 1999 No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumors. Clin Endocrinol (Oxf) 50:343-346
26. Beuschlein F, Schulze E, Moro P, Gensheimer HP, Maser-Gluth C, Allolio B, Reincke M 1998 Steroid 21-hydroxylase mutation and 21-hydroxylase mRNA expression in human adrenocortical tumors. J Clin Endocrinol Metab 83:2585-2588
27. Reincke M, Peter M, Sippell WG, Allolio B Impairment of 11 β-hydroxylase but not 21-hydroxylase in adrenal "incidentaloma." Eur J Endocrinol 136:196-200
28. Patócs A, Tóth M, Barta C, Sasvári-Székely M, Varga I, Szücs N, Jakab C, Gláz E, Rácz K 2002 Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur J Endocrinol 147:349-355
29. Baumgartner-Parzer SM, Pauschenwein S, Waldhäusl W, Pölzler K, Nowotny P, Vierhapper H 2002 Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas. Clin Endocrinol 56:881-886
30. Tóth M, Rácz K, Adleff V, Varga I, Fütö, Jakab C, Karlinger K, Kiss R, Gláz E 2000 Comparative analysis of plasma 17hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy. J Endocr Invest 23:287-294